Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Current Pharmaceutical Design
|
June 13, 2009
Mast cells as target in cancer therapy
Tom Groot Kormelink, Abulikemu Abudukelimu, Frank A Redegeld
Biochemical Society Transactions
|
June 17, 2017
Learning to read and write in evolution: from static pseudoenzymes and pseudosignalers to dynamic gear shifters
Abulikemu Abudukelimu, Thierry D G A Mondeel, Matteo Barberis, et al.
Frontiers in Immunology
|
August 23, 2018
Predictable Irreversible Switching Between Acute and Chronic Inflammation
Abulikemu Abudukelimu, Matteo Barberis, Frank A Redegeld, et al.
Frontiers in Immunology
|
March 3, 2020
Complex Stability and an Irrevertible Transition Reverted by Peptide and Fibroblasts in a Dynamic Model of Innate Immunity
Abulikemu Abudukelimu, Matteo Barberis, Frank Redegeld, et al.
Oncotarget
|
June 17, 2014
Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation
Tom Groot Kormelink, Desmond G Powe, Sylvia A Kuijpers, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Current Pharmaceutical Design
|
June 13, 2009
Mast cells as target in cancer therapy
Tom Groot Kormelink, Abulikemu Abudukelimu, Frank A Redegeld
Biochemical Society Transactions
|
June 17, 2017
Learning to read and write in evolution: from static pseudoenzymes and pseudosignalers to dynamic gear shifters
Abulikemu Abudukelimu, Thierry D G A Mondeel, Matteo Barberis, et al.
Frontiers in Immunology
|
August 23, 2018
Predictable Irreversible Switching Between Acute and Chronic Inflammation
Abulikemu Abudukelimu, Matteo Barberis, Frank A Redegeld, et al.
Frontiers in Immunology
|
March 3, 2020
Complex Stability and an Irrevertible Transition Reverted by Peptide and Fibroblasts in a Dynamic Model of Innate Immunity
Abulikemu Abudukelimu, Matteo Barberis, Frank Redegeld, et al.
Oncotarget
|
June 17, 2014
Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation
Tom Groot Kormelink, Desmond G Powe, Sylvia A Kuijpers, et al.
Page
of 1